期刊文献+

n-3、n-6PUFA高脂饮食对SD大鼠肝脏胆固醇合成相关基因表达影响 被引量:2

Effects of high-fat diet rich in n-3 or n-6PUFA on the expression of related genes regulating hepatic cholesterol synthesis in SD rats
下载PDF
导出
摘要 目的探讨n-3、n-6多不饱和脂肪酸(PUFA)高脂饮食对SD大鼠肝脏Srebp2及Hmgcr表达的影响。方法 SD大鼠随机分为3组,分别为对照组(NC)、n-3 PUFA组(TUF)及n-6 PUFA组(SUF),8周后测量血清总胆固醇(TCH)水平,实时定量PCR检测Srebp2及Hmgcr基因表达,Western blotting检测SREBP2及HMGCR蛋白表达。结果 TUF组、SUF组血清TCH含量均显著降低(P<0.001),TUF组最低。TUF组、SUF组Srebp2及Hmgcr基因表达水平均显著增高(P=0.007,P=0.012),SUF组Srebp2最高,TUF组Hmgcr最高。TUF组HMGCR蛋白表达显著高于NC组及SUF组,SUF组与NC组差异无显著性;三组SREBP2蛋白表达。结论 n-3、n-6PUFA降低血清胆固醇不是通过抑制Srebp2及Hmgcr表达实现的。 Objective To investigate the effects of high-fat diet rich in n-3 or n-6PUFA on the expressions of Srebp2 and Hmgcr in SD rats. Methods Eighteen normal male SD rats were randomly divided into 3 groups, including normal control group (NC) , high-n-3PUFA formula diet group (TUF) and high-n-6PUFA formula diet group (SUF) (n = 6). After 8 weeks, the total serum cholesterol (TCH) was measured. Srebp2 and Hmgcr gene expressions were detected by quantitative real-time PCR and the proteins were observed by Western blotting. Results Serum TCH in both the TUF and SUF groups were significantly lower than that of the NC group ( P 〈 0. 001 ), and that in the TUF group was the lowest. Meanwhile, gene expressions of Srebp2 and Hmgcr in both the TUF and SUF groups were significantly higher than that of the NC group (P =0. 007, P =0. 012). Western blotting showed that HMGCR in the TUF group was higher than that in the NC and SUF groups, while it was not significantly different between SUF and NC groups. There was no significant difference among the SREBP2 expressions in the three groups. Conclusions Overfeeding of n-3 or n-6PUFA reduces the serum TCH in rats, but it is not resulted from the inhibition of Srebp2 and Hmgcr expressions.
出处 《中国实验动物学报》 CAS CSCD 2013年第4期26-29,共4页 Acta Laboratorium Animalis Scientia Sinica
基金 国家自然科学基金面上项目(NO.31071986)
关键词 多不饱和脂肪酸 胆固醇合成 固醇调节元件结合蛋白Ⅱ 3-羟基-3-甲基戊二酰辅酶A还原酶 Poly-unsaturated fatty acid Cholesterol synthesis SREP2 HMGCR Rats
  • 相关文献

参考文献18

  • 1Clarke SD, Baillie R, Jump DB, et al. Fatty acid regulation of gene expression. Its role in fuel partitioning and insulin resistance [J]. Ann N YAcadSei, 1997. 827: 175-187.
  • 2景沛.胆固醇代谢调节分子机理研究新进展[J].生命的化学,1994,14(6):16-17. 被引量:1
  • 3Min HK, Kapoor A, Fuchs M, et al. Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease [ J ]. Cell Metab, 2012. 15(5) : 665 -674.
  • 4Kim HJ, Miyazaki M, Man WC, et al. Sterol regulatory element- binding proteins (SREBPs) as regulators of lipid metabolism: poly- unsaturated fatty acids oppose cholesterol-mediated induction of SREBP-1 maturation [J]. Ann N Y Acad Sci, 2002. 967:34 -42.
  • 5洪涛,涂晶,董艳华,钟警,文芳,文格波.利拉鲁肽对高脂饮食喂养大鼠的血脂谱的调节作用[J].中国医药导报,2012,9(19):16-17. 被引量:5
  • 6Chen Y, Hughes-Fulford M. Human prostate cancer cells lack feedback regulation of low-density lipoprotein receptor and its reg- ulator, SREBP2 [J]. Int J Cancer, 2001. 91(1) : 41 -45.
  • 7Xu G, Muller O, Stange EF, et al. Impaired regulation of sterol regulatory element binding protein 2 in cholesterol gallstone-sus- ceptible mice [J]. Biochim Biophys Acta, 2004. 1688(3) : 274 - 279.
  • 8Horton JD, Shah NA, Warrington JA, et al. Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes [ J ]. Proc Natl Acad SciU SA,2003. 100(21): 12027 -12032.
  • 9李伯良,段治军.胆固醇代谢平衡调控的分子机理[J].生物工程进展,1996,16(5):27-33. 被引量:11
  • 10卓伟华,王继文,蒋立.固醇调节元件结合蛋白在动物脂肪代谢中的研究进展[J].中国畜牧杂志,2005,41(2):39-41. 被引量:3

二级参考文献31

  • 1Raun K,Von VP,Gotfredsen CF,et al. Liraglutide,a long-acting glucagon- like peptide-1 analog,reduces body weight and food intake in obese candy-fed rats,whereas a dipeptidyl peptidase-IV inhibitor,vildagliptin, does not [J]. Diabetes, 2007,56 : 8-15.
  • 2Sarruf DA,Thaler JP,Morton GJ,et al. Fibroblast growth factor 21 action in the brain increases energy expenditure and insulin sensitivity in obese rats [J]. Diabetes,2010,59:1817-1824.
  • 3Yie J,Hecht R,Patel J,et al. FGF21 N-and C-termini play different roles in receptor interaction and activation [J]. Febs Lett,2009,583:19- 21.
  • 4Zhang X,Yeung DC,Karpisek M,et al. Serum FGF-21 levies are increased in obesity and independently associated with the metabolic syndrome in humans [J]. Diabetes,2008,57:1246-1253.
  • 5Horton J D, Goldstein J L, Brown M S. SREBPs:activators of the complete program of cholesterol and fatty acid synthesis in the liver[J]. J Clin Invest, 2002, 109 (9): 1125-1131.
  • 6Hua X, Wu J, Goldstein J L, et al. Structure of the human gene encoding sterol regulatory element binding protein-1 (SREBP-1) and localization of SREBP-1 and SREBP-2 to chromosomes 17pl 1.2 and 22q13 [ J ] . Genomics, 1995, 25(3) : 667-673.
  • 7Gondret F, Ferre P, Dugail I. ADD-1/SREBP-1 is a major determinant of tissue differential lipogenic capacity in mammalian and avian species[J]. J Lipid Res, 2001, 42 (1):106-113.
  • 8Shimano H. Sterol regulatory element-binding proteins(SREBPs) : transcriptional regulators of lipid synthetic genes[J]. Prog Lipid Res, 2001, 40 (6): 439-452.
  • 9Schweizer M, Roder K, Zhang L, et al. Transcription factors acting on the promoter of the rat fatty acid synthase gene[J].Biochem Soc Tran, 2002, 30 (Pt 6) : 1070-1072.
  • 10Yin L, Zhang Y, Hillgartner F B. Sterol regulatory elementbinding protein-1 interacts with the nuclear thyroid hormone receptor to enhance acetyl-CoA carboxylase-alpha transpription in hepatocytes[J]. J Biol Chem, 2002, 277 (2):19554-19565.

共引文献22

同被引文献21

  • 1贾乙,李晓辉.炎症因素在泡沫细胞形成中的作用及三七皂苷对其影响[J].第三军医大学学报,2005,27(10):972-974. 被引量:27
  • 2Charakida M, O' Nell F, Stefano Masi S, et al. Inflammatory disorders and atheroselerosis : new therapeutic approaches [J] Curt Pharmaceuti Design, 2012, 17(37): 4111 -4120.
  • 3Glass CK, Witztum JL. Atheroselerosis: the road ahead[J ] Cell, 2001, 104(4) :503 -16.
  • 4Ishwarlal J, Sridevi D. C-reactive protein : risk mark or mediator in atherosclerosis [J]. Hypertension,20(O;44( 1 ) : 6 - 11.
  • 5Shashkin SP, Dragulev B, Ley K. Macrophage differentiation to foam cells [J]. Curr Pharm Des,2005, 11 (23) :3061 - 3072.
  • 6Getz GS, Reardon CA. Animal models of atheroselerosis [ J ]. Arterioseler Thromb Vase Biol, 2012, 32(5) :1104 -1115.
  • 7Paoletti R, Cotto Jr AM, Hajjar DP. Inflammation in atherosele- rosis and implications for therapy [ J]. Circulation, 2004, 109 ( Suppl. 1 ) : 11120 - 26.
  • 8Kapourehali FR, Surendiran G, Cheu L, et al. Animal models of atheroselerosis [ J ]. World J Clin Cases, 2014,2 ( 5 ) : 126 - 132.
  • 9Bentzon JF, Falk E. Atheroselerotie lesions in mouse and man: is it the same disease? [ J ]. Curt Opin Lipidol, 2010,21 ( 5 ) : 434 - 440.
  • 10Jia W, Cao L, Yang S, et al. Regulatory T cells arc protective in systemic inflammation response syndrome induced by zymosan in mice [J]. PLoS ONE, 2013, 8(5) : e64397.

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部